Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance

Inclusion Criteria: * Drug-naive Type 2 diabetics with a screening HbA1c of ≥ 7.5% and ≤ 10% * Screening FPG ≥ 140 mg/dL and ≤ 220 mg/dL * BMI ≤ 40 kg/m2 Exclusion Criteria: * Active tuberculosis * Symptoms of poorly controlled diabetes * History of diabetic ketoacidosis * Significant cardiovascular history or gastrointestinal disorders * History of unstable or rapidly progressing renal disease * Active liver disease and/or significant abnormal liver function * Abnormal chest x-ray at screening indicative of tuberculosis or other infection